Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8736857 | Clinical Microbiology Newsletter | 2018 | 6 Pages |
Abstract
Over the past two decades, we have been confronted with an increase in the frequency and diversity of multi-drug-resistant microorganisms, leading in some cases to serious and life-threatening infections. To compound the problem, during the same timeframe, we have seen a significant decrease in the number of new, FDA-approved antimicrobial agents to treat these infections. In order to understand the gravity of the problem, we need to address the reasons behind the dramatic increase in antimicrobial resistance and the consequences facing us, as well as potential solutions to the problem.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Robert L. Ph.D., HCLD/CC (ABB), Diane C. Ph.D., DABMM, FAAM,